AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 17673038
Drug: Weight loss
RxNorm normalized name: HERBAL WEIGHT LOSS AID
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weight loss and metformin (500 mg three times daily)
Trial: 17673038
Drug: Weight loss
RxNorm normalized name: HERBAL WEIGHT LOSS AID
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weight loss and rosiglitazone (4 mg once daily)
Trial: 18226045
Drug: Raloxifene treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Raloxifene treatment
Trial: 12001016
Drug: Oral load
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral load of 300 ml of magnesium-rich mineral water (1.2 mmol Mg)
Trial: 12001016
Drug: Intravenous injection
RxNorm normalized name: Meta Trace FDG, intravenous injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous injection of (28)Mg
Trial: 10048795
Drug: High-Fat (HF)
RxNorm normalized name: Hard fat
DrugBank: Hard fat (DB11578)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-Fat (HF) treatment
Trial: 10048795
Drug: High-Carbohydrate (HC)
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-Carbohydrate (HC) treatment
Trial: 10048795
Drug: High-Protein (HP)
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-Protein (HP) treatment
Trial: 10048795
Drug: Equal mixture
RxNorm normalized name: brown mixture
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Equal mixture (M) treatment (33% protein)
Trial: 1919343
Drug: Admission to
RxNorm normalized name: Wong To Yick
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Admission to hospital and treatment with intravenous antibiotics
Trial: 29140444
Drug: 1-2 doses
RxNorm normalized name: riboflavin 1.2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1-2 doses of 15 μg GI.1/50 μg GII.4c formulation
Trial: 26562363
Drug: Dexmedetomidine (low
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexmedetomidine (low dose: target plasma concentration of 0.2 ng/ml)
Trial: 2014928
Drug: Aqueous BSA
RxNorm normalized name: ethylcellulose aqueous dispersion type A
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aqueous BSA solution (10 mg/mL) in a titrated double‐blind, placebo‐controlled bronchial inhalation challenge.
Trial: 2014928
Drug: Albuterol metered
RxNorm normalized name: albuterol Metered Dose Inhaler
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albuterol metered dose inhaler and avoidance of laboratory exposure to BSA.
Trial: 6750813
Drug: 100 g
RxNorm normalized name: Berri-Freez 4.5 GM per 100 GM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 g oral glucose load
Trial: 27678151
Drug: BCAA supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BCAA supplementation (12g daily for 12 weeks)
Trial: 26448183
Drug: Positive verbal
RxNorm normalized name: salicylic acid
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Positive verbal suggestion (inert capsule said to be effective for reducing physical sensitivity)
Trial: 23839537
Drug: MF59-adjuvanted vaccine
RxNorm normalized name: respiratory syncytial virus pre-fusion F protein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MF59-adjuvanted vaccine (ADV)
Trial: 23839537
Drug: Intradermal vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intradermal vaccine (IDV)
Trial: 23839537
Drug: Subunit vaccine
RxNorm normalized name: covid-19, protein subunit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subunit vaccine (TIV)
Trial: 21223356
Drug: SB-742457 (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SB-742457 (50 mg) + Risperidone (2 mg)
Trial: 21223356
Drug: SB-742457 (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SB-742457 (50 mg)
Trial: 14719048
Drug: Risperidone (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Risperidone (2 mg)
Trial: 15507864
Drug: Medium-dose balsalazide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medium-dose balsalazide alone
Trial: 12622761
Drug: Controlled-release (Entocort)
RxNorm normalized name: Afeditab CR
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Controlled-release (Entocort) capsules
Trial: 8588056
Drug: lorazepam 3
RxNorm normalized name: lorazepam 3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: lorazepam 3 or 4 mg tid
Trial: 1778878
Drug: Once-daily amikacin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once-daily amikacin dosing (od)
Trial: 1778878
Drug: Twice-daily amikacin
RxNorm normalized name: clindamycin
DrugBank: Clindamycin (DB01190)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Twice-daily amikacin dosing (bd)
Trial: 30664639
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg fluoxetine
Trial: 24035633
Drug: Lurasidone 80
RxNorm normalized name: lurasidone 80 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lurasidone 80 mg/day
Trial: 23421963
Drug: Lurasidone 120
RxNorm normalized name: lurasidone 120 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lurasidone 120 mg/day
Trial: 24073841
Drug: Lurasidone (80-160
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lurasidone (80-160 mg/day)
Trial: 17705186
Drug: Lamivudine therapy
RxNorm normalized name: Lamivudine
DrugBank: Lamivudine (DB00709)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Lamivudine therapy
Trial: 12627352
Drug: Lamivudine therapy
RxNorm normalized name: Lamivudine
DrugBank: Lamivudine (DB00709)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Lamivudine therapy for up to 4 years
Trial: 16623000
Drug: Intravenous hydrocortisone
RxNorm normalized name: Hydrocortisone
DrugBank: Hydrocortisone succinate (DB14545)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Intravenous hydrocortisone 100 mg
Trial: 6435772
Drug: Alfentanil (new
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alfentanil (new analgesic supplement)
Trial: 29236238
Drug: 5-week online
RxNorm normalized name: mitapivat
DrugBank: Mitapivat (DB16236)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 5-week online guided self-help intervention based on problem-solving therapy
Trial: 26896473
Drug: Tetrahydrobiopterin (BH4)
RxNorm normalized name: 6R-BH4
DrugBank: Sapropterin (DB00360)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Tetrahydrobiopterin (BH4) 400 mg single dose
Trial: 26896473
Drug: Tetrahydrobiopterin (BH4)
RxNorm normalized name: 6R-BH4
DrugBank: Sapropterin (DB00360)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Tetrahydrobiopterin (BH4) 400 mg once daily for 1 week
Trial: 24876957
Drug: Pregabalin 300
RxNorm normalized name: pregabalin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pregabalin 300 mg and Dexamethasone 8 mg
Trial: 12944340
Drug: Moclobemide (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moclobemide (400 mg/day)
Trial: 2140382
Drug: Clomipramine (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clomipramine (150 mg/day)
Trial: 21718165
Drug: Dexamethasone 8
RxNorm normalized name: dexamethasone 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone 8 mg twice a day (b.i.d) starting 24 h prior to ascent
Trial: 2661989
Drug: Ambroxol (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ambroxol (30 mg, 2 sachets daily for 10 days)
Trial: 2661989
Drug: Acetylcysteine (200-300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetylcysteine (200-300 mg, 2-3 sachets daily for 10 days)
Trial: 15711607
Drug: Bicalutamide 50
RxNorm normalized name: bicalutamide 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bicalutamide 50 mg o.d.
Trial: 15711607
Drug: Cyproterone acetate
RxNorm normalized name: cyproterone acetate
DrugBank: Cyproterone acetate (DB04839)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyproterone acetate 100 mg t.i.d.
Trial: 12478216
Drug: Triazolam (0.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triazolam (0.25 mg/70 kg)
Trial: 12680736
Drug: d-Amphetamine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: d-Amphetamine (20 mg/70 kg)
Trial: 12680736
Drug: Triazolam (0.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triazolam (0.25 mg/70 kg) and d-Amphetamine (20 mg/70 kg) conjointly
Trial: 8628802
Drug: Textured implants
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Textured implants
Trial: 24180235
Drug: Ma Zi
RxNorm normalized name: ZINC OXIDE 20 g in 100 g TOPICAL OINTMENT [Ancalima Zinc Oxide]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ma Zi Ren Wan and western medicine placebo
Trial: 24180235
Drug: Senna and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Senna and Chinese medicine placebo
Trial: 24180235
Drug: Chinese medicine
RxNorm normalized name: BUTYLENE GLYCOL 48 g in 240 mL CUTANEOUS TAPE [QIZHOUGUAI Chinese medicine patch]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chinese medicine placebo and western medicine placebo
Trial: 21518647
Drug: Control nostrils
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control nostrils (no honey treatment)
Trial: 19143666
Drug: High-threshold group
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-threshold group (phototherapy interrupted when TSB decreased to >/=1 mg/dL below limit)
Trial: 19143666
Drug: Low-threshold group
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-threshold group (phototherapy interrupted when TSB decreased to >/=3 mg/dL below limit)
Trial: 15200755
Drug: Ezetimibe 10
RxNorm normalized name: ezetimibe 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ezetimibe 10 mg plus lovastatin 40 mg
Trial: 15200755
Drug: Lovastatin 20
RxNorm normalized name: lovastatin 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lovastatin 20 mg alone
Trial: 3055325
Drug: Disulfiram administration
RxNorm normalized name: Disulfiram
DrugBank: Disulfiram (DB00822)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Disulfiram administration (Group 1)
Trial: 23815562
Drug: Olmesartan/Amlodipine combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olmesartan/Amlodipine combination (20/5 mg)
Trial: 16091994
Drug: Breathing rate
RxNorm normalized name: cetylpyridinium chloride Mouthwash [Breath-Away]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Breathing rate of 10 L/min
Trial: 12173800
Drug: Aerosolized ceftazidime
RxNorm normalized name: Ceftazidime
DrugBank: Ceftazidime (DB00438)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aerosolized ceftazidime 250 mg every 12 hours for up to 7 days
Trial: 21452030
Drug: HPV vaccine
RxNorm normalized name: HPV vaccine 9-valent/PF 0.5 mL INTRAMUSC VIAL (ML)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HPV vaccine radionovela
Trial: 12150647
Drug: Group Cognitive-Behavioral
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group Cognitive-Behavioral Therapy (CBT)
Trial: 19176275
Drug: Enhanced Supportive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enhanced Supportive Therapy (ST)
Trial: 17101746
Drug: Modified-release zolpidem
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Modified-release zolpidem (12.5 mg)
Trial: 17101746
Drug: Immediate-release zolpidem
RxNorm normalized name: zolpidem Extended Release Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate-release zolpidem (10 mg)
Trial: 15233714
Drug: Conflict-oriented in-patient
RxNorm normalized name: patent blue violet
DrugBank: Patent Blue (DB13967)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conflict-oriented in-patient therapy
Trial: 15233714
Drug: Systemic out-patient
RxNorm normalized name: Cough Out
DrugBank: Guaifenesin (DB00874)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Systemic out-patient therapy
Trial: 3113339
Drug: Conventional-dose group:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional-dose group: 600 mg of tegafur p.o. daily and 1-2 mg of lentinan i.v. weekly
Trial: 20973459
Drug: High-calcium fortified
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-calcium fortified milk (400 ml daily for 16 weeks)
Trial: 2048623
Drug: Occupational therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Occupational therapy intervention related to leisure activities
Trial: 28977347
Drug: Nutritional supplementation
RxNorm normalized name: Ocean Blue Nutritionals Omega-3 1450 Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nutritional supplementation (150 kcal, 20 g whey protein, 800 IU vitamin D, 119 mL beverage)
Trial: 28977347
Drug: Placebo (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (30 kcal, nonnutritive, 119 mL)
Trial: 26501267
Drug: Omega-3 PUFAs
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omega-3 PUFAs (600 mg EPA and 625 mg DHA per day)
Trial: 22691248
Drug: L. reuteri
RxNorm normalized name: L. reuteri
DrugBank: Lactobacillus reuteri (DB14224)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L. reuteri (108 CFU = 5 drops per day) for 60 days
Trial: 12524069
Drug: Flutamide (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flutamide (250 mg daily)
Trial: 9135694
Drug: Finasteride (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Finasteride (5 mg daily)
Trial: 10501359
Drug: Nebulised fenoterol
RxNorm normalized name: fenoterol
DrugBank: Fenoterol (DB01288)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nebulised fenoterol (after initial treatment)
Trial: 8927681
Drug: Olanzapine (two
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olanzapine (two doses)
Trial: 1909692
Drug: Placebo (0.05
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (0.05 ml/kg/day)
Trial: 6832465
Drug: Dithranol cream
RxNorm normalized name: Zithranol
DrugBank: Anthralin (DB11157)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dithranol cream 0.25%
Trial: 9567231
Drug: Spinal manipulative
RxNorm normalized name: Bos taurus spinal cord preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spinal manipulative therapy
Trial: 10825039
Drug: Intradermal bacille
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intradermal bacille Calmette‐Guérin (BCG) vaccination
Trial: 31377269
Drug: Methylnaltrexone (0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylnaltrexone (0.3 mg/kg intravenous)
Trial: 28127644
Drug: Far Infrared
RxNorm normalized name: Menthol/Methyl Salicylate 3%-0.5% Topical application Patch, Extended Release [GOLDEN SUNSHINE FAR INFRARED HOT HERBAL]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Far Infrared Radiation (FIR) treatment
Trial: 9333593
Drug: Magnesium treatment
RxNorm normalized name: Magnesium
DrugBank: Magnesium (DB14513)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Magnesium treatment
Trial: 6093241
Drug: Cefotaxime (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefotaxime (1 g i.m. every 12 hours to a total of 3 g)
Trial: 16761235
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no antibiotic)
Trial: 21034160
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy of MSX and CC
Trial: 16938159
Drug: Haloperidol 1
RxNorm normalized name: haloperidol 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Haloperidol 1 mg intravenous
Trial: 12552184
Drug: Ondansetron 4
RxNorm normalized name: ondansetron 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ondansetron 4 mg intravenous
Trial: 16602440
Drug: Serum copper
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Serum copper concentration in RA patients (19.1 +/- 4.5 micromol/L)
Trial: 12379846
Drug: Pre-aggregated Abeta42
RxNorm normalized name: Albumin Aggregated
DrugBank: Albumin Aggregated (DB14230)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pre-aggregated Abeta42 vaccination (primary injection followed by booster injection)
Trial: 9627891
Drug: Mandibular implant-supported
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mandibular implant-supported overdentures
Trial: 7936862
Drug: Measles-mumps-rubella-varicella vaccine
RxNorm normalized name: varicella-zoster virus vaccine live (Oka-Merck) strain
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Measles-mumps-rubella-varicella vaccine
Trial: 23926584
Drug: All-on-2 implants
FDA approved: no
EMA approved: no
PMDA approved: no
Description: All-on-2 implants
Trial: 23926584
Drug: All-on-4 implants
FDA approved: no
EMA approved: no
PMDA approved: no
Description: All-on-4 implants
Trial: 12520528
Drug: ED-71 (0.25,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ED-71 (0.25, 0.5, 0.75, and 1.0 microgram) administered orally daily for 6 months
Trial: 11099743
Drug: Fluoxetine 20
RxNorm normalized name: fluoxetine 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine 20 mg + Clonazepam 0.5-1.0 mg
Trial: 7815703
Drug: Midazolam 4
RxNorm normalized name: Midazolam
DrugBank: Midazolam (DB00683)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Midazolam 4 mg
Trial: 8968175
Drug: Midazolam 8
RxNorm normalized name: Midazolam
DrugBank: Midazolam (DB00683)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Midazolam 8 mg
Trial: 27029706
Drug: Placebo plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo plus weekly paclitaxel
Trial: 24882176
Drug: Therapist-assisted internet
RxNorm normalized name: Moisturel Therapeutic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Therapist-assisted internet cognitive behavioural treatment (iCBT) program
Trial: 23864802
Drug: D-002 (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: D-002 (100 mg/day)
Trial: 17024953
Drug: Red wine
RxNorm normalized name: Red wine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Red wine staining solution
Trial: 17024953
Drug: Night Effects
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Night Effects bleaching agent
Trial: 17024953
Drug: Simply White
RxNorm normalized name: SODIUM FLUORIDE 0.0024 g in 1 g DENTAL PASTE, DENTIFRICE [Simply White Sweet Mint]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simply White Night bleaching agent
Trial: 17024953
Drug: Opalescence Quick
RxNorm normalized name: Cal-Quick
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Opalescence Quick bleaching agent
Trial: 23544125
Drug: Ezetimibe 10
RxNorm normalized name: ezetimibe 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ezetimibe 10 mg/d
Trial: 10406828
Drug: Troglitazone (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Troglitazone (400 mg/d)
Trial: 27417982
Drug: Low-intensity strategy
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-intensity strategy (control arm) utilizing a licensed practical nurse for bi-monthly, non-tailored behavioral support calls.
Trial: 23910952
Drug: Algorithm-based treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Algorithm-based treatment with basal-bolus insulin therapy
Trial: 8096956
Drug: Mefloquine (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mefloquine (25 mg/kg)
Trial: 15904617
Drug: Laparoscopic hysterectomy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Laparoscopic hysterectomy with vaginal cuff suspension (LHS group)
Trial: 15904617
Drug: Laparoscopic hysterectomy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Laparoscopic hysterectomy without vaginal cuff suspension (LH group)
Trial: 8760238
Drug: Control infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Control infusion of Hartman's solution at 4 ml/min for 210 min
Trial: 1718364
Drug: Cisapride 20
RxNorm normalized name: cisapride 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisapride 20 mg given orally with MST 20 mg
Trial: 6808542
Drug: Low nicotine
RxNorm normalized name: Nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Low nicotine content (0.2 mg) cigarette
Trial: 30465630
Drug: mHealth technology‐enabled,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: mHealth technology‐enabled, nurse‐guided intervention with a Blue-toothed BP device and smartphone App for monitoring BP measurements and medication intake for three months
Trial: 25822674
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of radioisotope and blue dye
Trial: 24054830
Drug: Ciprofloxacin DPI
RxNorm normalized name: Ciprofloxacin
DrugBank: Ciprofloxacin (DB00537)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ciprofloxacin DPI 65 mg once daily (qd) for 7 days (n=6)
Trial: 24054830
Drug: Ciprofloxacin DPI
RxNorm normalized name: Ciprofloxacin
DrugBank: Ciprofloxacin (DB00537)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ciprofloxacin DPI 32.5 mg twice daily (bid) for 7 days (n=6)
Trial: 10922131
Drug: Both therapies
RxNorm normalized name: Theraplex Eczema Therapy
DrugBank: Colloidal oatmeal (DB11286)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both therapies
Trial: 11576818
Drug: Hormone therapy
RxNorm normalized name: INVESTIGATIONAL HORMONE THERAPY/REPLACEMENT,OTHER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hormone therapy
Trial: 11788660
Drug: Carbenoxolone (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carbenoxolone (100 mg every 8 h for 7 d)
Trial: 10235511
Drug: WR 6026
FDA approved: no
EMA approved: no
PMDA approved: no
Description: WR 6026 at 120 mg/day for 21 days
Trial: 10235511
Drug: WR 6026
FDA approved: no
EMA approved: no
PMDA approved: no
Description: WR 6026 at 150 mg/day for >19 days
Trial: 8767368
Drug: Nocturnal oxygen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nocturnal oxygen administration
Trial: 2024744
Drug: Continuous lumbar
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous lumbar plexus block with 0.5% bupivacaine and adrenaline (0.3 ml/kg)
Trial: 7014058
Drug: Aspirin, 600
RxNorm normalized name: Aspirin, 600 mg rectal suppository
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin, 600 mg, b.i.d.